title: Clinical and Demographics Characteristics of Non-Valvular Atrial Fibrillation Patients Switching From Warfarin To Novel Oral Anticoagulants.
authors.affiliation: Bristol-Myers Squibb Company, Princeton, NJ, USA.
authors.forename: S
authors.initials: S
authors.lastname: Kachroo
authors.affiliation: Bristol-Myers Squibb, New Haven, CT, USA.
authors.forename: X
authors.initials: X
authors.lastname: Pan
authors.affiliation: Pfizer, New York, NY, USA.
authors.forename: L
authors.initials: L
authors.lastname: Liu
authors.affiliation: Bristol-Myers Squibb, Hopewell, NJ, USA.
authors.forename: H
authors.initials: H
authors.lastname: Kawabata
authors.affiliation: Bristol-Myers Squibb Company, Princeton, NJ, USA.
authors.forename: H
authors.initials: H
authors.lastname: Phatak